AirSculpt Technologies, Inc. Announces Launch of Public Offering of Common Stock
Public Offering Announcement: AirSculpt Technologies, Inc. has launched an underwritten public offering of 3.16 million common shares to reduce debt and fund general operations, with the option for underwriters to purchase an additional 474,000 shares.
Use of Proceeds: The proceeds from the offering will be used for prepaying existing debt and for general corporate purposes, including working capital, as indicated by the company and its sole bookrunner, Leerink Partners.
Trade with 70% Backtested Accuracy
Analyst Views on AIRS
About AIRS
About the author


Market Performance: Hospital and medical practitioners' shares are down approximately 1.7% on Friday, with Agilon Health and AirSculpt Technologies leading the decline at 9% and 8.3%, respectively.
Sector Laggards: The construction sector, along with hospital and medical practitioners, is identified as a laggard in the market on Friday.
Video Coverage: A video segment highlights the performance of these sectors, focusing on the laggards in the market.
Author's Perspective: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Oversold Stocks in Health Care: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with a Relative Strength Index (RSI) below 30.
Inotiv Inc Performance: Inotiv Inc reported strong contract awards and anticipates fourth-quarter revenue between $137.5 million and $138.5 million, despite its stock falling 38% recently, with an RSI of 26.7.
Airsculpt Technologies Update: Airsculpt Technologies faced disappointing third-quarter results and lowered its FY25 revenue outlook, leading to a 60% stock drop over the past month, with an RSI of 29.3.
Neuronetics Sales Guidance: Neuronetics cut its FY2025 sales guidance, resulting in a 40% decline in stock value over the past month, and it currently has an RSI of 23.9.
Appointment of New Chairman: AirSculpt Technologies has appointed Mike Doyle as the Non-Executive Chairman of its Board of Directors, bringing over 30 years of experience in the multi-center healthcare sector.
Leadership Experience: Doyle has a strong background in scaling healthcare organizations, having previously served as CEO of Surgery Partners and held leadership roles in various healthcare boards.
CEO's Statement: Yogi Jashnani, CEO of AirSculpt, expressed enthusiasm about Doyle's appointment, highlighting his experience in partnering with surgeons and developing new service lines.
About AirSculpt: AirSculpt offers a next-generation body contouring treatment that is minimally invasive, focusing on comfort and precision, with quick healing and minimal bruising.
South Florida Real Estate Boom: South Florida has seen a surge in $100 million home sales, attracting high-end listings in the ultrahigh market.
Record-Setting Mansion Listing: A nearly-completed mansion on Indian Creek is set to hit the market for $200 million, potentially becoming the most expensive sale in Miami-Dade County history.
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow up slightly by 0.06%, while the Nasdaq fell by 0.45% and the S&P 500 dropped by 0.04%.
Sector Movements: Energy shares increased by 1.2%, while communication services stocks saw a decline of 1.8%.
Consumer Sentiment Index: The University of Michigan's consumer sentiment index fell to 50.3 in November, down from 53.6 the previous month, missing market expectations.
Notable Stock Movements: Motorsport Games Inc. shares surged by 79% after positive sales results, while AirSculpt Technologies Inc. shares plummeted by 42% due to disappointing financial results.

Stock Performance: AirSculpt Technologies, Inc. (AIRS) experienced a significant drop of 42.76% in stock price, falling to $6.01 after disappointing third-quarter fiscal 2025 results.
Financial Results: The company reported a revenue of $35.0 million, a 17.8% decrease Year-over-Year, and an expanded net loss of $9.5 million compared to a loss of $6.0 million the previous year.
Revised Outlook: AirSculpt lowered its full-year 2025 revenue forecast to approximately $153 million from an earlier estimate of $160-$170 million, indicating weaker demand in the body-contouring market.
Market Reaction: Following the announcement, AIRS experienced heavy trading volume as investors reacted to the growth miss and reduced guidance, with the stock's 52-week range noted between $2.60 and $12.50.








